Paraquat Lawsuit 2026: MDL 3004 Status, the Parkinson's Link & Who Can Still File
Thousands of farmworkers and applicators who mixed or sprayed the weed killer paraquat — sold for decades as Gramoxone — have sued its makers, alleging the exposure raised their risk of Parkinson's disease. About 6,600 federal cases now sit in a single courtroom in southern Illinois, a master settlement agreement was signed in September 2025, and its payment terms remain confidential.
- MDL 3004 in the U.S. District Court for the Southern District of Illinois, before Chief Judge Nancy J. Rosenstengel — 6,602 cases pending as of October 1, 2026.
- A Master Settlement Agreement was signed on September 3, 2025; no payout grid or payment schedule has been made public.
- A 2011 peer-reviewed study (Tanner et al.) found roughly 2.5 times the odds of Parkinson's disease among people who had used paraquat.
- The EPA opened a safety review in January 2026; Vermont banned paraquat in May 2026 and California began phasing it out in August 2026.
- Syngenta announced in March 2026 that it will stop manufacturing paraquat — past exposure is not erased.
For an in-depth video explainer of how these cases work, see our channel: Problem Solved on YouTube.
What the Paraquat Lawsuits Allege
Paraquat is one of the most tightly restricted herbicides in American agriculture — federal rules bar even a licensed applicator from handing the sprayer to someone working under their supervision. Sold since the 1960s as Gramoxone, Firestorm, and Parazone, it was a workhorse weed killer on farms, orchards, and plantations.
The lawsuits allege that the manufacturers — principally Syngenta and Chevron — knew or should have known that long-term exposure could increase the risk of Parkinson's disease, yet failed to warn workers. Parkinson's disease is a progressive neurological disorder marked by tremor, slowed movement, stiffness, and balance problems. These are allegations, not findings: no manufacturer has been found liable, and the science remains contested.
The Science Behind the Parkinson's Link
The most-cited study is a 2011 paper in Environmental Health Perspectives (Tanner et al.), which found about 2.5 times the odds of Parkinson's disease among pesticide applicators who had used paraquat.
In January 2026 the agency opened a fresh safety review, and it still has not required a Parkinson's warning on the label.
MDL 3004: Where the Federal Cases Stand
A multidistrict litigation (MDL) moves similar federal lawsuits before a single judge for coordinated pretrial proceedings. The paraquat cases were centralized as MDL 3004 in June 2021. The docket held 6,602 pending actions on October 1, 2026; thousands more proceed in state courts.
In spring 2025 the parties announced a settlement in principle and the court paused much of the litigation. In March 2026 the court approved a Qualified Settlement Fund, canceled the April 2026 trial, and appointed a Special Master to communicate settlement terms — a clear move into settlement administration rather than toward trial.
The September 2025 Settlement: What Is Public — and What Isn't
The Master Settlement Agreement signed on September 3, 2025 says almost nothing public about money: no payout grid, no court-ordered compensation schedule, no approved payment timeline. Any page quoting a specific per-person amount is estimating.
Compensation in mass torts varies widely by case — it turns on exposure evidence, diagnosis timing and severity, and documented damages. No reliable public per-case figures exist because the terms are confidential. What is visible is friction: the court has scrutinized high opt-out rates at several firms, and plaintiffs who declined the settlement face "Lone Pine" orders requiring early proof of exposure and injury. New claims are still being filed and reviewed.
2026 Regulatory Developments
- January 2026: the EPA announced a new safety review of paraquat.
- March 2026: Syngenta announced it will end production of the herbicide.
- May 2026: Vermont became the first U.S. state to ban paraquat.
- August 2026: California began phasing it out after manufacturers voluntarily canceled state registrations.
None of this erases past exposure — but it explains why lawyers keep accepting new paraquat cases.
Who May Qualify for a Paraquat Claim
Most claimants mixed, loaded, sprayed, or worked closely around paraquat products — farmers, licensed applicators, farmworkers, and sometimes rural residents near treated fields — and were later diagnosed with Parkinson's disease or parkinsonism. The threshold questions are work history, product exposure, and diagnosis. Parkinson's often appears years after exposure, which complicates timing — and makes early legal review more important, not less.
How Claims Are Filed — and What It Costs to Ask
These are individual lawsuits filed through a law firm of the claimant's choosing — not a class action with a sign-up check. Firms generally work on contingency: free consultation, no upfront fee, paid as a percentage of any recovery. Exposure-based cases follow a familiar pattern — see our Roundup lawsuit guide and the PFAS water contamination lawsuit for how such MDL claims are built.
Exposure is easier to prove with paper: applicator licenses and training certificates, spray logs and purchase receipts naming the product, employment records showing where and when the work happened, photos of equipment or labels, and medical records documenting the diagnosis. Federal rules require private applicators to keep restricted-use pesticide records for two years, so recent records may still exist. You do not need a perfect file to ask — as with the mesothelioma claims process, the sooner the review, the more options remain.
Deadlines: Why Waiting Is the Costliest Mistake
Every state sets its own statute of limitations, and the clock does not always start at exposure — with Parkinson's latency, when it started is often the most contested issue in a case. The litigation being "still open" does not mean your window is: a prompt no-cost case review is the single most valuable step.
This article is general information about ongoing litigation, not legal advice. For advice about your situation, consult a qualified attorney.
Who Benefits From This — and Who Does Not
This guide serves farmworkers, applicators, and their families who are weighing a paraquat claim — but the claim turns on exposure and diagnosis, and some readers will find it does not fit.
Who benefits:
- Farmworkers and applicators who mixed or sprayed paraquat, sold for decades as Gramoxone. Document the product, period, and tasks, since compensation turns on exposure evidence, diagnosis timing and severity, and documented damages.
- People diagnosed with Parkinson’s disease after paraquat exposure. Compare the case against the “Who May Qualify” section and get a prompt deadline review — new claims are still being filed and reviewed while the MDL remains active.
- Families helping an exposed worker understand the litigation. Use the MDL 3004 status — 6,602 federal cases pending as of October 1, 2026 — and the fact that the September 2025 settlement terms remain confidential to set realistic expectations.
Who does not benefit:
- People with no paraquat exposure. The lawsuits allege an exposure-related risk; without exposure there is no claim of this kind.
- People without a Parkinson’s diagnosis. The allegation is specifically the Parkinson’s link, which manufacturers contest and no court has found proven against a manufacturer.
- Anyone relying on a quoted per-person settlement amount. No payout grid or payment schedule has been made public; any page quoting a specific per-person amount is estimating.
Related reading: hernia mesh lawsuits.
Frequently Asked Questions
Is the paraquat lawsuit a class action?
No. The federal cases are consolidated as MDL 3004 for coordinated pretrial proceedings, but each claim remains an individual lawsuit evaluated on its own exposure and medical facts.
How much is the paraquat settlement per person?
No reliable public per-person figure exists. The September 2025 Master Settlement Agreement has confidential payment terms — no published payout grid, no court-approved schedule. Compensation varies widely by case.
Do I need to have been a farmer to qualify?
Not necessarily. Most claimants mixed or sprayed paraquat as farmers, applicators, or farmworkers, but some lived or worked near treated fields. The key questions are documented exposure and a Parkinson's diagnosis.
What if I was diagnosed years after exposure ended?
That is the norm here, not the exception — Parkinson's often develops years later. The latency complicates the filing deadline, which is why prompt legal review matters even for long-ago exposure.
Is it too late to file a paraquat claim in 2026?
Not necessarily — new cases are still being filed and the MDL remains active. But each state's statute of limitations sets its own deadline, so waiting can close your window while the litigation continues.
Who benefits from this guide — and who is unlikely to qualify?
Farmworkers and applicators exposed to paraquat and later diagnosed with Parkinson’s disease benefit most, since the litigation turns on exposure evidence and diagnosis. People with no paraquat exposure, or without a Parkinson’s diagnosis, are unlikely to qualify — and no one should rely on a quoted per-person amount, because the September 2025 settlement terms remain confidential.